The drugmaker said it was initiating a regular quarterly cash dividend of 70 cents per share. The company was created when Dublin-based Actavis bought the Botox maker in March 2015, snatching it from hostile bidder Valeant Pharmaceuticals Inc , and taking on the Allergan name. Allergan Chief Executive Brent Saunders has orchestrated a string of smaller acquisitions since the company's planned $160-billion merger with Pfizer Inc collapsed in April, due to new U.S. tax regulations.
Original post:
Allergan expands buyback to $15 billion, sets first quarterly dividend
